生命科学资讯

What Sanofi’s multiple sclerosis troubles could mean for the space

Thermo Fisher Chief Operating Officer Michel Lagarde Leaving Company - The Wall Street Journal

Thermo Fisher Chief Operating Officer Michel Lagarde Leaving Company - The Wall Street Journal

Thermo Fisher Chief Operating Officer Michel Lagarde Leaving Company - The Wall Street Journal

Eikon next in line for IPO, with funds set to bankroll clutch of clinical cancer drugs

'An undoing of the scientific method': Flagship CEO warns of government threats to US biotech industry

#JPM26: Moderna CEO Bancel talks deals, flu and RSV strategy

Novartis, SciNeuro to work together on preclinical amyloid-targeting drug for Alzheimer’s

Kinaset rakes in $103M to advance inhaled asthma drug

Thermo Fisher Scientific announces executive departures and leadership changes - Investing.com

Thermo Fisher Scientific Announces Executive Leadership Changes - TradingView — Track All Markets

5 questions facing biopharma in 2026

Building more sustainable cold chain packaging through innovation

Best practices for COA selection: Building a stronger foundation for clinical trials

Balanced Risk/Reward Keeps 10x Genomics at Hold Despite Solid Execution and Discounted Valuation - TipRanks

10x Genomics (TXG) Sees Modest Q4 Growth Amid Revenue Challenges - GuruFocus

China’s biotech moment goes global, Zai Lab exec says

Ohio Bets on Workforce Training to Capture Boom in Biomanufacturing, Digital Health

Quest Diagnostics highlights role of in vitro diagnostics in precision medicine

10x Genomics sees uptick in Q4 revenue despite softer FY sales (TXG:NASDAQ) - Seeking Alpha